This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This educational and promotional event is organised and funded by Flynn Pharma Ltd.

The Treatment of ADHD in Patients with Comorbid Conditions, including Foetal Alcohol Spectrum Disorder (FASD)

This event took place on Monday 2 December 2024
Your certificate will be available in your account once you have watched the on-demand video.

Agenda

The Treatment of ADHD in Patients with Comorbid Conditions, including Foetal Alcohol Spectrum Disorder (FASD), Professor Raja Mukherjee, Consultant Psychiatrist, AMD LD, Clinical Lead Adult NDD & FASD, Foetal Alcohol Spectrum Disorders Service, Surrey and Borders Partnership NHS Foundation Trust; Honorary Professor University of Salford, Visiting Professor, University of Surrey, Honorary Fellow University of Western Australia
Professor Raja Mukherjee
Professor Raja Mukherjee
Consultant Psychiatrist, AMD LD, Clinical Lead Adult NDD & FASD, Foetal Alcohol Spectrum Disorders Service, Surrey and Borders Partnership NHS Foundation Trust; Honorary Professor University of Salford, Visiting Professor, University of Surrey, Honorary Fellow University of Western Australia

Professor Raja Mukherjee is an Adult Learning Disability Consultant Psychiatrist for Surrey and Borders Partnership NHS Foundation Trust, with interest in the management of developmental disorders across the lifespan. In September 2009 he started the first NHS based specialist Fetal Alcohol Spectrum Disorders behavioural clinic and since then has seen over 250 cases for specialist second opinion as a national referral service. Dr Mukherjee completed his PhD on the subject of Fetal Alcohol Syndrome in 2014. He has also acted as an invited advisor to the BMA board of science, The Department of Health and the World Health Organisation on the subject of FASD. In 2015 Dr Mukherjee also gave evidence to the first All Party Parliamentary Group on FASD at the House of Commons. He has continued to support national clinical developments related to FASD. Dr Mukherjee is a member of the NICE quality standards group for FASD. He is currently the only UK representative to a US, NIH sponsored initiative to consider the research criteria for FASD. In his own time, he volunteers as a medical advisor to various FASD charities both in the UK and internationally. In 2021 he was made an Honorary Professor at the University of Salford related to his work on FASD. In wider work, he is currently the Clinical Lead for Adult neurodevelopmental services provided by Surrey and Borders including Adult ASD and ADHD services across Surrey, Hampshire and Portsmouth. He is a an executive committee member of the RCPsych SIG on neurodevelopmental disorders, taking over as Finance officer from July 2021.

What will the webinar cover?

Key learning objectives

  • To explore the diagnosis and management of ADHD and comorbid conditions including Foetal Alcohol Spectrum Disorders (FASD)